Elanco Animal Health Incorporated Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment
Elanco Animal Health Incorporated (ELAN) reported Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment of -$21.00 million for the 1-month period ending 2019-09-30, per its 10-K filed 2022-02-28.
Discontinued › Notes › Defined Benefit Plan
us-gaap:DefinedBenefitPlanPlanAmendments · last filed 2022-02-28
- 2019-09-30: Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment 1 month -$21.00M.
| Period end | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment 1 month |
|---|---|
| 2019-09-30 | -$21.00M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |